Literature DB >> 3103366

Continuous monitoring of oxygen tension with a transcutaneous sensor during hypotensive anesthesia.

J Megerman, P T Mihelakos, A N Katsamouris, N R Fahmy, D G Lappas, W M Abbott.   

Abstract

Transcutaneous oxygen tension (TCPO2) is a useful noninvasive technique for monitoring arterial oxygen tension under stable circulatory conditions. This study was undertaken to determine if TCPO2 is also reliable during sodium nitroprusside-induced hypotension under general anesthesia. Arterial blood gases and TCPO2 were measured prior to inducing hypotension (baseline), at 20-min intervals during hypotension, and when systemic arterial pressure had returned to within 10% of the control (pre-hypotension) value. With induced hypotension, PaO2 and TCPO2 decreased significantly (P less than 0.05), and were well correlated by linear regression (r greater than 0.85); however, regressions were strongly dependent on the individual patient. The mean regression line for all patients as a group was given by TCPO2 = 0.69 PaO2 + 20.7 mmHg (r = 0.93, P less than 0.01); significantly different regressions were obtained for each patient (P less than 0.0001). Comparing changes in TCPO2 versus those in PaO2 (relative change from baseline values) did not substantially reduce the variability among patients. It is concluded that TCPO2 reliably reflects changes in arterial oxygen tension during controlled hypotension under general anesthesia, but that a separate calibration of TCPO2 vs. PaO2, obtained prior to inducing hypotension, may be required for each individual patient.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3103366     DOI: 10.1111/j.1399-6576.1987.tb02514.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  1 in total

1.  Detection of microcirculatory impairment by transcutaneous oxymetry monitoring during hemodialysis: an observational study.

Authors:  Ygal Benhamou; Loic Begarin; Nathalie David; Nicole Cailleux; Catherine Bessin; Herve Lévesque; Stephane Edet
Journal:  BMC Nephrol       Date:  2014-01-08       Impact factor: 2.388

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.